l General Information |
Product Name | Trelagliptin succinate |
General description | Trelagliptin succinate is a dipeptidyl peptidase IV (DPP-4) inhibitor which is used as a new long-acting drug for once-weekly treatment of type 2 diabetes mellitus (DM). |
Synonym | Trelagliptin (Succinate) |
Purity | ≥99.0%(HPLC) | CAS Number | 1029877-94-8 |
Formula | C22H26FN5O6 | Molecular Weight | 475.47 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Solid |
Solubility(25°C) | DMSO | ≥50mg/ml |
Ethanol | ~5mg/ml |
Water | ≥50mg/ml |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
